GVHD

Clinical trials for GVHD explained in plain language.

Never miss a new study

Get alerted when new GVHD trials appear

Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Terminated 1

Blood cancer transplant study tests blood pressure drug to prevent immune attack

Disease control Terminated

This study looked at whether the blood pressure drug telmisartan could prevent a serious complication called graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. About 32 participants were planned, but the study was stopped early. The goa…

Matched conditions: GVHD

Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control

Last updated Apr 28, 2026 13:02 UTC

GVHD

Get alerted when new GVHD trials appear

Blood cancer transplant study tests blood pressure drug to prevent immune attack